Draft Genome Sequence of the Mucoid Pseudomonas aeruginosa Clinical Isolate PA34

Lucas B Harrison1, Nancy D Hanson2

  • 1Department of Medical Microbiology and Immunology, Creighton University, Omaha, Nebraska, USA.

Genome Announcements
|November 18, 2017
PubMed

Insights

This study sequenced the genome of a mucoid Pseudomonas aeruginosa strain from a cystic fibrosis patient. Understanding this pathogen

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa poses a significant threat to individuals with cystic fibrosis.
  • The lung environment imposes unique selective pressures on P. aeruginosa.
  • Mucoid strains are frequently observed in cystic fibrosis patients.

Purpose of the Study:

  • To present the draft genome sequence of a mucoid P. aeruginosa clinical isolate.
  • To provide a genomic resource for studying P. aeruginosa adaptation in cystic fibrosis lungs.

Main Methods:

  • Whole-genome sequencing of a mucoid P. aeruginosa clinical isolate.
  • Bioinformatic analysis of the draft genome.

Main Results:

  • The draft genome sequence of the mucoid P. aeruginosa isolate is reported.
  • The genome provides insights into genetic factors potentially involved in mucoid conversion and persistence.

Conclusions:

  • The availability of this genome sequence facilitates further research into P. aeruginosa pathogenesis in cystic fibrosis.
  • This genomic data can aid in the development of targeted therapeutic strategies.

Related Concept Videos